Kanülenbasierte Injektionssysteme zur medizinischen Verwendung - Anforderungen und Prüfverfahren - Teil 1: Kanülenbasierte Injektionssysteme - Änderung 1 (ISO 11608 1:2022/Amd 1:2026)

Systèmes d'injection à aiguille pour usage médical - Exigences et méthodes d'essai - Partie 1: Systèmes d'injection à aiguille - Amendement 1 (ISO 11608-1:2022/Amd1:2026)

Peresa za injiciranje za uporabo v medicini - Zahteve in preskusne metode - 1. del: Peresa za injiciranje - Dopolnilo A1 (ISO 11608-1:2022/FDAmd1:2026)

General Information

Status
Published
Publication Date
05-May-2026
Current Stage
6060 - Definitive text made available (DAV) - Publishing
Start Date
06-May-2026
Completion Date
06-May-2026

Relations

Effective Date
12-Feb-2026
Effective Date
16-Oct-2024

Overview

EN ISO 11608-1:2022/A1:2026 is the latest amendment to the standard for needle-based injection systems (NIS) for medical use, specifically focusing on part 1: requirements and test methods. Published by CEN and developed through collaboration with ISO and technical committee ISO/TC 84, this amendment enhances the clarity and consistency of terminology and updates procedural details related to the testing and evaluation of injection systems. The amendment ensures alignment and precision across documentation, improving how manufacturers and stakeholders approach terminology, inspection, and performance verification for medical injection devices.

Key Topics

  • Terminology Consistency: Editorial inconsistencies are addressed, ensuring uniform use of terms such as “anticipated/normal conditions,” “in-use conditions,” “conditioning,” and “preconditioning.”

  • Primary Function Identification: Clarified guidelines require the identification of primary functions via assessment of design specifications, emphasizing dose delivery and accuracy.

  • Test Methods and Apparatus Requirements: Updated requirements for measurement systems specify accuracy, precision, repeatability, and reproducibility, particularly for high-precision test apparatus used in NIS evaluation.

  • Dosing Regions Procedures: Revised notes provide clearer guidance for dividing container contents for dosing evaluation, supporting more accurate system testing.

  • Test Case Matrix: The amendment summarizes required tests under different conditions and outlines the sequence for visual inspections and primary function assessments.

  • Verification Under Varying Conditions: The amendment strengthens requirements for conducting inspections and assessments both after stressed/challenge conditions and under normal/anticipated conditions.

  • Life-cycle and Functional Stability: Life-cycle testing now applies a defined safety factor, and “functional stability” encompasses both shelf-life and in-use life, underscoring the importance of system reliability from manufacture to disposal.

  • Risk and Harm Assessment: The amendment clarifies the distinction between evaluating essential performance based on both likelihood and severity of harm, and identifying primary functions based solely on severity.

Applications

This standard amendment is essential for:

  • Medical Device Manufacturers: Helps in the development and production of reliable, safe needle-based injection systems such as insulin pens, prefilled syringes, and auto-injectors. The clarified requirements improve the accuracy of design verification and validation processes.

  • Regulatory Compliance: Provides a harmonized reference for demonstrating conformity with European and international regulatory requirements, streamlining pathways for product approval and market access.

  • Quality Assurance and Testing Laboratories: Enables testing bodies to implement robust, reproducible, and compliant methods for product evaluation, ensuring consistent performance and safety over the product’s lifecycle.

  • Healthcare Providers and End-Users: Enhances confidence in the reliability and safety of injection systems, minimizing risks associated with dosing inaccuracies or device failure.

Related Standards

For a comprehensive approach to needle-based injection system safety and performance, consider the following related standards:

  • ISO 11608 Series: Covers additional requirements for accessories, drug containers, pen-injectors, and more.
  • EN ISO 23908: Focuses on sharps injury protection for medical devices.
  • ISO 14971: Medical devices - Application of risk management to medical devices.
  • ISO 10993 Series: Biocompatibility evaluation of medical device materials.

By adopting EN ISO 11608-1:2022/A1:2026, stakeholders support consistent terminology, thorough testing, and enhanced safety for needle-based injection systems, ensuring better protection for patients and healthcare professionals.

Buy Documents

Draft

EN ISO 11608-1:2022/oprA1:2025

English language (6 pages)
Preview
Preview
e-Library read for
1 day

Get Certified

Connect with accredited certification bodies for this standard

BSI Group

BSI (British Standards Institution) is the business standards company that helps organizations make excellence a habit.

UKAS United Kingdom Verified

TÜV Rheinland

TÜV Rheinland is a leading international provider of technical services.

DAKKS Germany Verified

TÜV SÜD

TÜV SÜD is a trusted partner of choice for safety, security and sustainability solutions.

DAKKS Germany Verified

Sponsored listings

Frequently Asked Questions

EN ISO 11608-1:2022/A1:2026 is a draft published by the European Committee for Standardization (CEN). Its full title is "Needle-based injection systems for medical use - Requirements and test methods - Part 1: Needle-based injection systems - Amendment 1 (ISO 11608-1:2022/Amd1:2026)". This standard covers: Needle-based injection systems for medical use - Requirements and test methods - Part 1: Needle-based injection systems - Amendment 1 (ISO 11608-1:2022/Amd1:2026)

Needle-based injection systems for medical use - Requirements and test methods - Part 1: Needle-based injection systems - Amendment 1 (ISO 11608-1:2022/Amd1:2026)

EN ISO 11608-1:2022/A1:2026 is classified under the following ICS (International Classification for Standards) categories: 11.040.25 - Syringes, needles an catheters. The ICS classification helps identify the subject area and facilitates finding related standards.

EN ISO 11608-1:2022/A1:2026 has the following relationships with other standards: It is inter standard links to ISO 11608-1:2022/Amd 1:2026, EN ISO 11608-1:2022. Understanding these relationships helps ensure you are using the most current and applicable version of the standard.

EN ISO 11608-1:2022/A1:2026 is available in PDF format for immediate download after purchase. The document can be added to your cart and obtained through the secure checkout process. Digital delivery ensures instant access to the complete standard document.

Standards Content (Sample)


SLOVENSKI STANDARD
SIST EN ISO 11608-1:2022/oprA1:2025
01-september-2025
Peresa za injiciranje za uporabo v medicini - Zahteve in preskusne metode - 1. del:
Peresa za injiciranje - Dopolnilo A1 (ISO 11608-1:2022/DAmd1:2025)
Needle-based injection systems for medical use - Requirements and test methods - Part
1: Needle-based injection systems - Amendment 1 (ISO 11608-1:2022/DAmd1:2025)
Kanülenbasierte Injektionssysteme zur medizinischen Verwendung - Anforderungen und
Prüfverfahren - Teil 1: Kanülenbasierte Injektionssysteme - Änderung 1 (ISO 11608
1:2022/DAmd 1:2025)
Systèmes d'injection à aiguille pour usage médical - Exigences et méthodes d'essai -
Partie 1: Systèmes d'injection à aiguille - Amendement 1 (ISO 11608-
1:2025/DAmd1:2025)
Ta slovenski standard je istoveten z: EN ISO 11608-1:2022/prA1:2025
ICS:
11.040.25 Injekcijske brizge, igle in Syringes, needles an
katetri catheters
SIST EN ISO 11608-1:2022/oprA1:2025 en,fr,de
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.

SIST EN ISO 11608-1:2022/oprA1:2025

SIST EN ISO 11608-1:2022/oprA1:2025
DRAFT
Amendment
ISO 11608-1:2022/
DAM 1
ISO/TC 84
Needle-based injection systems for
Secretariat: DS
medical use — Requirements and
test methods —
Voting begins on:
2025-07-29
Part 1:
Voting terminates on:
Needle-based injection systems 2025-10-21
AMENDMENT 1
Systèmes d'injection à aiguille pour usage médical — Exigences
et méthodes d'essai —
Partie 1: Systèmes d'injection à aiguille
AMENDEMENT 1
ICS: 11.040.25
THIS DOCUMENT IS A DRAFT CIRCULATED
FOR COMMENTS AND APPROVAL. IT
IS THEREFORE SUBJECT TO CHANGE
AND MAY NOT BE REFERRED TO AS AN
INTERNATIONAL STANDARD UNTIL
PUBLISHED AS SUCH.
This document is circulated as received from the committee secretariat.
IN ADDITION TO THEIR EVALUATION AS
BEING ACCEPTABLE FOR INDUSTRIAL,
TECHNOLOGICAL, COMMERCIAL AND
USER PURPOSES, DRAFT INTERNATIONAL
STANDARDS MAY ON OCCASION HAVE TO
ISO/CEN PARALLEL PROCESSING
BE CONSIDERED IN THE LIGHT OF THEIR
POTENTIAL TO BECOME STANDARDS TO
WHICH REFERENCE MAY BE MADE IN
NATIONAL REGULATIONS.
RECIPIENTS OF THIS DRAFT ARE INVITED
TO SUBMIT, WITH THEIR COMMENTS,
NOTIFICATION OF ANY RELEVANT PATENT
RIGHTS OF WHICH THEY ARE AWARE AND TO
PROVIDE SUPPORTING DOCUMENTATION.
Reference number
ISO 11608-1:2022/DAM 1:2025(en)

SIST EN ISO 11608-1:2022/oprA1:2025
DRAFT
ISO 11608-1:2022/DAM 1:2025(en)
Amendment
ISO 11608-1:2022/
DAM 1
ISO/TC 84
Needle-based injection systems for
Secretariat: DS
medical use — Requirements and
test methods —
Voting begins on:
Part 1:
Voting terminates on:
Needle-based injection systems
AMENDMENT 1
Systèmes d'injection à aiguille pour usage médical — Exigences
et méthodes d'essai —
Partie 1: Systèmes d'injection à aiguille
AMENDEMENT 1
ICS: 11.040.25
THIS DOCUMENT IS A DRAFT CIRCULATED
FOR COMMENTS AND APPROVAL. IT
IS THEREFORE SUBJECT TO CHANGE
AND MAY NOT BE REFERRED TO AS AN
INTERNATIONAL STANDARD UNTIL
PUBLISHED AS SUCH.
This document is circulated as received from the committee secretariat.
IN ADDITION TO THEIR EVALUATION AS
BEING ACCEPTABLE FOR INDUSTRIAL,
© ISO 2025
TECHNOLOGICAL, COMMERCIAL AND
USER PURPOSES, DRAFT INTERNATIONAL
All rights reserved. Unless otherwise specified, or required in the context of its implementation, no part of this publication may
STANDARDS MAY ON OCCASION HAVE TO
ISO/CEN PARALLEL PROCESSING
be reproduced or utilized otherwise in any form or by any means, electronic or mechanical, including photocopying, or posting on
BE CONSIDERED IN THE LIGHT OF THEIR
the internet or an intranet, without prior written permission. Permission can be requested from either ISO at the address below
POTENTIAL TO BECOME STANDARDS TO
WHICH REFERENCE MAY BE MADE IN
or ISO’s member body in the country of the requester.
NATIONAL REGULATIONS.
ISO copyright office
RECIPIENTS OF THIS DRAFT ARE INVITED
CP 401 • Ch. de Blandonnet 8
TO SUBMIT, WITH THEIR COMMENTS,
CH-1214 Vernier, Geneva
NOTIFICATION OF ANY RELEVANT PATENT
Phone: +41 22 749 01 11
RIGHTS OF WHICH THEY ARE AWARE AND TO
PROVIDE SUPPORTING DOCUMENTATION.
Email: copyright@iso.org
Website: www.iso.org
Published in Switzerland Reference number
ISO 11608-1:2022/DAM 1:2025(en)

ii
SIST EN ISO 11608-1:2022/oprA1:2025
ISO 11608-1:2022/DAM 1:2025(en)
Foreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards
bodies (ISO member bodies). The work of preparing International Standards is normally carried out through
ISO technical committees. Each member body interested in a subject for which a technical committee
has been established has the right to be represented on that committee. International organizations,
governmental and non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely
with the International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization.
The procedures used to develop this document and those intended for its further maintenance are described
in the ISO/IEC Directives, Part 1. In particular, the different approval criteria needed for the different types
of ISO documents should be noted. This document was drafted in accordance with the editorial rules of the
ISO/IEC Directives, Part 2 (see www.iso.org/directives).
ISO draws attention to the possibility that the implementation of this document may involve the use of (a)
patent(s). ISO takes no position concerning the evidence, validity or applicability of any claimed patent
rights in respect thereof. As of the date of publication of this document, ISO had not received notice of (a)
patent(s) which may be required to implement this document. However, implementers are cautioned that
this may not represent the latest information, which may be obtained from the patent database available at
www.iso.org/patents. ISO shall not be held responsible for identifying any or all such patent rights.
Any trade name used in this document is information given for the convenience of users and does not
constitute an endorsement.
For an explanation of the voluntary nature of standards, the meaning of ISO specific terms and expressions
related to conformity assessment, as well as information about ISO's adherence to the World Trade
Organization (WTO) principles in the Technical Barriers to Trade (TBT), see www.iso.org/iso/foreword.html.
This document was prepared by Technical Committee ISO/TC 84, Devices for administration of medicinal
products and catheters.
This amendment addresses editorial inconsistencies with regards to terminology introduced in the
last revision, e.g. use of "anticipated/normal conditions" vs. "in-use conditions" and interchangeable and
inconsistent use of "conditioning" and "preconditioning".
In addition, it tries to improve subclause 10.2 with regards to the sequence of visual inspection and
assessment of primary functions.
It does not introduce new requirements, and it does not change existing requirements.
A list of all parts in the ISO 11608 series can be found on the ISO website.
Any feedback or questions on this document should be directed to the user’s national standards body. A
complete listing of these bodies can be found at www.iso.org/members.html.

iii
SIST EN ISO 11608-1:2022/oprA1:2025

-----------
...